Table 3 Occurrence of TAVR implantation related complications according to the available prosthesis.

SAPIEN

7.09 ± 4.36

37/10,768

11.02 ± 7.22

12/3,435

2.40

1/419

3.04 ± 3.57

17/3,711

6.99 ± 9.70

12/1731

1.41 ± 2.11

7/826

SAPIEN XT

8.59 ± 3.41

40/13,008

4.89 ± 3.53

16/1934

2.65 ± 0.21

2/289

1.74 ± 1.40

16/2,937

15.80 ± 17.81

11/1,190

2.00 ± 1.21

4/900

SAPIEN 3

11.51 ± 4.48

26/5,948

2.04 ± 2.61

22/4,260

1.40

1/815

0.87 ± 2.17

10/3,711

5.33 ± 8.16

9/983

0.00 ± 0.00

8/952

CoreValve

25.38 ± 10.32

90/26,188

15.70 ± 9.64

45/12,481

1.15 ± 0.21

2/1,485

1.96 ± 2.90

21/12,673

24.25 ± 12.80

17/9,061

0.35 ± 0.64

11/5,127

LotusValve

28.64 ± 6.62

19/2,935

0.65 ± 1.27

11/1571

0.12/0.30

12/923

0.51 ± 1.44

13/942

n.a

0/0

0.48 ± 0.44

5/738

ACURATE Neo

7.10 ± 2.82

3/158

0.00 ± 0.00

4/132

3.40

1/89

0.275 ± 0.55

4/162

33.63 ± 8.97

3/44

0.00 ± 0.00

4/133

ACURATE TA

3.75 ± 5.30

2/50

0.00 ± 0.00

2/50

n.a

0/0

0.00

1/10

n.a

0/0

n.a

0/0

Portico

10.04 ± 3.77

5,484

2.38 ± 2.17

4/262

n.a

0/0

0.00

1/22

9.10

1/22

0.00

1/102

Direct flow medical

13.98 ± 6.79

9/960

1.25 ± 1.77

2/218

1.75 ± 1.65

6/512

6.68 ± 5.80

4/422

n.a

0/0

1.60 ± 2.62

2/281

JenaValve

14.40

1/180

0.00

1/27

n.a

0/0

2.80

1/180

n.a

0/0

0.00

1/180

Evolut R

14.08 ± 2.58

5/1,499

4.00 ± 3.42

5/1,499

0.150 ± 0.30

4/1,425

0.00 ± 0.00

2/146

21.70

1/60

0.10 ± 0.20

4/1,425

Engager

19.20 ± 8.83

3/101

0.00

1/30

n.a

0/0

10

1/30

3.30

1/30

n.a

0/0